好的，这是一份根据你提供的来源和我们的对话历史整理的本次课程课堂笔记：

# Chapter 16: Cancer / 第十六章：癌症

## Learning Objectives / 学习目标

- To master the basic characteristics of cancer. / 掌握癌症的基本特征。
- To understand gene mechanisms involved in tumor development. / 理解肿瘤发生过程中基因机制的作用。
- To know how to combat with cancers. / 了解如何对抗癌症。

## 16.1 Basic Properties of a Cancer Cell / 癌细胞的基本特性

Cancer cells possess fundamental characteristics that distinguish them from normal somatic cells. / 癌细胞具有区分于正常体细胞的基本特征。

- **Sustained proliferative signaling**: Cancer cells stimulate their own growth continuously. / **持续的增殖信号**: 癌细胞持续刺激自身生长。
- **Evade growth suppressors**: They escape from growth suppressors or growth-inhibiting signals. / **逃避生长抑制物**: 它们逃避生长抑制因子或抑制生信号。
- **Resist cell death**: Cancer cells resist apoptosis (programmed cell death), enabling survival despite damage or stress. / **抵抗细胞死亡**: 癌细胞抵抗凋亡（程序性细胞死亡），使其在遭受损伤或压力时仍能存活。
- **Enable replicative immortality**: Some cancer cells acquire genetic changes that prevent senescence, allowing indefinite proliferation. / **赋予复制不朽能力**: 一些癌症获得遗传改变，避免衰老，从而实现无限期增殖。
- **Induce angiogenesis**: They affect other cells to make new blood vessels (angiogenesis) for blood supply. Tumor cells stimulate new blood vessel formation in their environment to get nutrients. / **诱导血管生成**: 它们影响其他细胞生成新血管（血管生成）以供血。肿瘤细胞刺激其周围环境中的新血流形成以获得营养物质。
- **Activate invasion and metastasis**: Cancer cells actively participate in spreading disease (metastasis). Cells become invasive due to alterations affecting adhesion molecules, leading to detachment from original tissue sites and spread via the bloodstream or lymphatics. / **启动侵袭与转移**: 癌细胞积极参与疾病传播（转移）。细胞由于粘附分子的变化而变得具有侵袭性，导致从原位脱落并通过血液或淋巴管扩散。

Compared to normal cells which grow as monolayers in culture dishes and have uniform shapes, **cancer cells grow in clumps called foci**. / 与在培养皿中以单层生长、形状均匀的正常细胞相比，**癌细胞以团块(称为灶状）生长**。 Malignant tumor formation involves abnormal growth of tissue into irregular clusters. / 恶性肿瘤形成涉及组织异常生长成不规则的团块。

Cancer cells often exhibit **highly aberrant chromosome complements**, termed aneuploidy (非整倍体). This may be due to defects in the mitotic checkpoint or an abnormal number of centrosomes. Examples include altered numbers of individual chromosomes and chromosomes composed of pieces from different chromosomes. / 癌细胞常表现出**高度异常的染色体组成**，称为非整倍体。这可能是由于有丝分裂检查点缺陷或中心粒数量异常导致。例如，单个染色体数量发生改变，以及许多染色体是由不同染色体的片段组合而成。

Regarding metabolism, differentiated tissue typically uses oxidative phosphorylation with oxygen, producing about 36 mol ATP/mol glucose. Proliferative tissue/tumors, with or without oxygen availability, often convert glucose to pyruvate and then to lactate. Cancer cells often depend on glycolysis, considered an anaerobic metabolic pathway. / 关于代谢，分化型组织通常在有氧条件下进行氧化磷酸化，每摩尔葡萄糖产生约36mol ATP。增殖期组织/肿瘤，无论有无氧气，通常将葡萄糖转化为丙酮酸，然后转化为乳酸。癌细胞通常依赖糖酵解，这被认为是一种厌氧代谢途径。

HeLa cells, derived from Henrietta Lacks' cervical cancer in 1951, were the first immortal human cells grown in culture and have been invaluable for over 74,000 research studies globally since the 1950s. / 海拉细胞来源于亨利埃塔·洛克斯1951年的宫颈癌，是世界上首次在体外培养成功的人类不死细胞，自上世纪五十年代以来，已在全球超过七万四千项研究中发挥了巨大价值。

## 16.2 The Causes of Cancer / 癌症的原因

Several factors can lead to an increased risk of cancer. / 有几种因素可以导致癌症风险增加。

Possible causes include: / 可能的原因包括：

- Smoking and Tobacco. Cigarette smoke contains over 24 cancer-causing chemicals. Smoking is responsible for one-third of cancer deaths globally and is one of the biggest single factors for lung cancer. / 吸烟和烟草。香烟烟雾含有超过24种致癌化学物质。吸烟占全球癌症死亡人数的三分之一，是肺癌最大的单一因素之一。
- Diet and Physical Activity. Diet can play a major role in the risk of developing cancer. / 饮食和体力活动。饮食在患癌风险中可起重要作用。
- Sun and Other Types of Radiation. Ultraviolet radiation is a leading cause of skin cancer and is strongly mutagenic. / 阳光和其他类型的辐射。紫外线辐射是皮肤癌的主要原因，并且是强诱变性的。
- Viruses and Other Infections. Virus-induced cancers represent only a minority (20%) of cancer types. Certain viral replication cycles force host cells to proliferate uncontrollably. Tumor viruses are broadly divided into DNA tumor viruses (e.g., Papillomavirus, Hepatitis-B virus, Hepatitis-C virus, Epstein–Barr virus) and RNA tumor viruses or retroviruses (e.g., HTLV-I, HIV). Examples of associated cancers include cervical cancer (Papillomavirus), liver cancer (Hepatitis-B/C), Burkitt's lymphoma (Epstein–Barr virus), and Kaposi’s sarcoma (HIV). Small sizes of tumor viruses make defining the responsible gene relatively easy. / 病毒和其他感染。病毒引起的癌症只占所有癌症类型的一小部分（20%）。某些病毒复制周期迫使宿主细胞无控制地繁殖。肿瘤病毒大致分为DNA肿瘤病毒（如乳头瘤病毒、乙肝病毒、丙肝病毒、EB病毒）和RNA肿瘤病毒或逆转录病毒（如HTLV-I、HIV）。相关的癌症包括宫颈癌（乳头瘤病毒）、肝癌（乙肝/丙肝）、伯基特淋巴瘤（EB病毒）和卡波济肉瘤（HIV）。小的肿瘤病毒使得定义导致转化的基因相对容易。

Carcinogenic chemicals, like those in soot or cigarette smoke, are either directly mutagenic or converted to mutagenic compounds by cellular enzymes. / 致癌化学物质，例如煤烟或香烟烟雾中的物质，要么直接具有致突变性，要么通过细胞酶转化为致突变化合物。

Common cancerous areas in the body include lung, breast (women), colon, bladder, and prostate (men). Leukemias affect the blood system, and lymphomas primarily attack lymph nodes. / 身体中常见的癌变区域包括肺部、乳腺（女性）、结肠、膀胱和前列腺（男性）。白血病影响血液系统，淋巴瘤主要攻击淋巴结。

Leading causes of death in the US (2019) include breast and lung cancer, with an estimated 1,762,450 new cases and 606,880 deaths. In China, age-standardized rates per 100,000 people show high incidence for men in stomach, lung, and liver cancers, and for women in stomach, lung, and breast cancers. / 根据美国2019年的主要死因估算，癌症新发病例总数约为1,762,450例，死亡人数约为606,880人，其中乳腺癌和肺癌是主要死因。在中国，每十万人的年龄标准化癌症发生率显示，男性高发癌症为胃癌、肺癌和肝癌，女性高发癌症为胃癌、肺癌和乳腺癌。

## 16.3 Cancer: A Genetic Disorder / 癌症是一种遗传性疾病

Cancer is considered a genetic disorder. The development of a malignant tumor (tumorigenesis) is a **multistep process** characterized by a progression of permanent genetic alterations within single lines of cells over many successive cell divisions, which can take decades to complete. / 癌症被认为是一种遗传性疾病。恶性肿瘤的发生（瘤的发生）是一个**多步骤过程**，其特征是单个细胞系中的永久遗传改变在许多次继发性的细胞分裂过程中逐渐积累，可能需要几十年的时间才能完成。

Genetic factors can influence overall development rates significantly through epigenetic mechanisms. Heredity plays only minor roles during progression stages but can influence overall development rates significantly. / 遗传因素可以通过表观遗传机制显著影响总体发展速度。遗传因素在进展阶段只起次要作用，但可以显著影响总体发展速度。

Genes involved in carcinogenesis are divided into two broad categories: **tumor-suppressor genes and oncogenes**. / 癌症发生过程中涉及的基因被分为两大类：**肿瘤抑制基因和致癌基因**。

- **Tumor-suppressor genes** act as a cell's "brakes". **They encode proteins that restrain cell growth and prevent cells from becoming malignant**. Examples include TP53 and WT1 (Transcription factors), RB and p16 (Cell cycle transcription regulation), NF1 (GTPase regulation), PTEN (PIP3 phosphatase), and VHL (Protein degradation). Mutation in genes like BRCA1 and BRCA2 increases the risk of breast cancer. Mutations in the RB gene can lead to retinoblastoma (视网膜母细胞瘤). In sporadic cases, mutations occur spontaneously in both alleles. In familial/inherited cases, one mutated copy is inherited. / **肿瘤抑制基因**充当细胞的“刹车”。**它们编码蛋白质，限制细胞生长并防止细胞恶性转化**。例如，TP53和WT1（转录因子），RB和p16（细胞周期转录调控），NF1（GTPase调节），PTEN（PIP3磷酸酶）和VHL（蛋白质降解）。BRCA1和BRCA2等基因的突变增加了乳腺癌的风险。RB基因的突变可导致视网膜母细胞瘤。在散发性病例中，两个等位基因都会发生自发突变。在家族/遗传性病例中，遗传一个突变拷贝。
    
    - **pRB** plays a role in controlling the transcription of genes required for cell cycle progression. During most of G1, unphosphorylated pRB is bound to E2F protein, acting as a transcriptional repressor. Phosphorylation of pRB by cyclin-dependent kinases prevents it from binding to E2F, converting DNA-bound E2F into an activator for target gene expression needed for G1/S transition. / **pRB**在控制细胞周期进程所需基因的转录中起作用。在G1期的大部分时间里，非磷酸化的pRB与E2F蛋白结合，充当转录阻遏物。周期蛋白依赖性激酶对pRB的磷酸化阻止其与E2F结合，将结合在DNA上的E2F转变为激活因子，从而激活G1/S转换所需靶基因的表达。
    - **p53** is described as the “guardian of the genome”. The TP53 gene encodes the p53 protein. Cell division normally does not require p53. If DNA damage occurs, the level of p53 rises, and it can either halt progression at G1 phase (G₁ arrest) for repair or initiate apoptosis if repair is not feasible. When both copies of the TP53 gene are inactivated, the cell loses the ability to arrest the cell cycle or undergo apoptosis following DNA damage, leading to uncontrolled growth that can develop into cancerous tumors. DNA damage initiates the activity of proteins encoded by both tumor-suppressor genes (like p53) and proto-oncogenes. / **p53**被描述为“基因组守护者”。TP53基因编码p53蛋白。正常细胞分裂通常不需要p53的参与。如果发生DNA损伤，p53水平升高，它可以阻止细胞周期在G1期进展（G₁阻滞）以进行修复，或者如果无法修复则启动凋亡。当TP53基因的两个拷贝都失活时，细胞在DNA损伤后失去阻止细胞周期或进行凋亡的能力，导致不受控制的生长，最终可能发展成癌症肿瘤。DNA损伤会引发肿瘤抑制基因（如p53）和原癌基因编码蛋白质的活性。
- **Oncogenes** **encode proteins that promote loss of growth control and conversion of cells to malignant states**. Most oncogenes act as "accelerators" of cell proliferation. They can also lead to genetic instability, prevent apoptosis, or promote metastasis. / **致癌基因**编码促进生长控制丧失和细胞恶性转化的蛋白质。大多数致癌基因充当细胞增殖的“加速器”。它们也可能导致遗传不稳定、阻止细胞凋亡或促进转移。
    
    - **Oncogenes derive from proto-oncogenes**. Proto-oncogenes encode proteins with various functions in normal cellular activities. Proto-oncogenes can be converted into activated oncogenes through mechanisms like point mutation (alters protein structure/function), amplification (gene duplication leading to increased synthesis/overexpression), or gene rearrangement/translocation (altering regulatory sequences or creating fusion proteins). / **致癌基因来源于原癌基因**。原癌基因编码在正常细胞活动中具有多种功能的蛋白质。原癌基因可以通过点突变（改变蛋白质结构/功能）、基因扩增（基因复制导致合成增加/过度表达）或基因重排/易位（改变调控序列或产生融合蛋白）等机制转化为激活的致癌基因。
    - Types of proteins encoded by oncogenes include growth factors or their receptors (e.g., PDGF, EGF), cytoplasmic protein kinases, transcription factors, proteins affecting the epigenetic state of chromatin, metabolic enzymes, and proteins affecting apoptosis. / 致癌基因编码的蛋白质类型包括生长因子或其受体（例如PDGF，EGF）、细胞质蛋白激酶、转录因子、影响染色质表观遗传状态的蛋白质、代谢酶和影响凋亡的蛋白质。

Tumors can arise from either tissue stem cells or progenitor cells. In some cases, different cellular origins lead to distinct cancer subtypes. / 肿瘤可以来源于组织干细胞或祖细胞。在某些情况下，不同的细胞起源导致不同的癌症亚型。

## 16.6 Strategies for Combating Cancer / 抗癌策略

Strategies for combating cancer include conventional approaches and newer methods. / 抗癌策略包括常规方法和较新的方法。

- **Conventional approaches**: Surgery, chemotherapy, and radiation. / **常规方法**: 手术、化疗和放疗。
- **Immunotherapy**: Harnessing the immune system to fight cancer. Many more cancers may be treated by immunotherapy in the future. The 2018 Nobel Prize in Physiology or Medicine was awarded for the discovery of cancer therapy by inhibition of negative immune regulation (PD-1 blockade). PD-1 blockade therapy efficacy has improved. PD-1 blockade enhances T-cell activation by preventing programmed cell death of immune cells. Antibodies targeting PD-L1 or PD-L2 on tumors and antigen-presenting cells inhibit signaling pathways leading towards apoptosis, allowing for sustained anti-tumor immunity mediated by activated T cells. / **免疫疗法**: 利用免疫系统对抗癌症。未来许多更多的癌症可能通过免疫治疗得到控制或治愈。2018年生理学或医学诺贝尔奖授予了通过抑制负向免疫调节治疗癌症的发现（PD-1阻断）。PD-1阻断疗法的有效性已得到提升。PD-1阻断通过阻止免疫细胞的程序性细胞死亡来增强T细胞活性。针对肿瘤和抗原呈递细胞上PD-L1或PD-L2的抗体抑制导致凋亡的信号通路，从而使活化的T细胞介导持续的抗肿瘤免疫。
- **Inhibiting the activity of cancer-promoting proteins**. This includes targeted molecular therapy. Targeted therapies can attack only cancer cells, leaving normal cells unharmed. They can target specific proteins whose inactivation prevents cancer cells from growing or surviving. Targeted therapy can also be personalized based on a patient's unique pattern of somatic mutations. Examples of targeted drugs include Gleevec/Tasigna (targeting BCR-ABL, KIT, PDGFR), Iressa/Tarceva (targeting EGFR), Sutent/Votrient (targeting VEGF-R, PDGF-R, Kit), and Zelboraf (targeting BRAFV600E). These drugs often act as tyrosine kinase inhibitors or kinase inhibitors.
- **The concept of a cancer stem cell**. / **癌症干细胞的概念**。
- **Inhibiting the formation of new blood vessels (Angiogenesis)**. Cancer cells promote angiogenesis by secreting growth factors like VEGF. These factors stimulate endothelial cells of nearby vessels to proliferate and develop into new vessels. Solid tumors, which remain small (1-2 mm) when avascular, become capable of unlimited growth once vascularized. Solid tumors might be destroyed by inhibiting their ability to form new blood vessels. / **抑制新血管生成（血管生成）**。癌细胞通过分泌VEGF等生长因子促进新生血管生成。这些因子刺激附近血管的内皮细胞增殖并发育成新血管。固体肿瘤在无血管时保持很小（1-2毫米），一旦血管化就能实现无限增长。通过抑制固体肿瘤形成新血管的能力，可以将其破坏。

Future prospects suggest that while cancer may not completely disappear, it could potentially become a chronic disease managed by therapies like immunotherapy. / 未来展望表明，虽然癌症可能不会完全消失，但有可能通过免疫疗法等手段成为一种慢性疾病进行管理。